about
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity.The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target.Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells.Regulation of Clusterin Gene Expression.Protein Kinase Targets in Breast Cancer.Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer.Bcl-2 Inhibition to Overcome Resistance to Chemo- and ImmunotherapyTargeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy.Targeting Receptor Kinases in Colorectal Cancer.Immunotherapy: A Challenge of Breast Cancer TreatmentFree Thyroxine Determination in the Emergency Department Is a Predictor of Acute Pancreatitis EvolutionFirst hospital contact via the Emergency Department is an independent predictor of overall survival and disease-free survival in patients with colorectal cancerClinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours
P50
Q36465338-06E040AD-9568-458E-A1BE-9389EBEF535AQ38805474-1FD3811E-2E3D-4E3B-A3D9-5E3AAC2D77CBQ38964076-799B6F19-038C-481F-A0F2-05BB4432F469Q47320105-9F8893F5-6B26-4D12-9EB3-D711820773E7Q47351355-2A155A48-7AD0-4B93-8DC1-AA813B05C72CQ50673804-3728B7AA-FAC4-4BF1-A940-07C77DA683EFQ60907777-3ABB1BF2-7D58-4294-9E11-3977B5AEC3D1Q64946532-703EE1F8-72D7-4F42-A1A3-8B9F8F842745Q64969873-0C143C10-8366-47BC-B808-00CFC35E6A76Q91399525-F09A01FB-0676-4405-B841-1AF9FA004FCDQ91424791-863EBC5D-8DCA-413A-9B4B-2D7FA6677A32Q92179209-E1EF0F93-5D1B-485D-BCDB-88F5213D8866Q92919796-F9B7DB96-4112-42F0-9826-E2D23A103E7B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria García-Aranda
@en
Maria García-Aranda
@nl
type
label
Maria García-Aranda
@en
Maria García-Aranda
@nl
prefLabel
Maria García-Aranda
@en
Maria García-Aranda
@nl
P31
P496
0000-0003-3759-4044